Renata Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Renata Limited with three other
pharmaceutical manufacturers in Asia:
Shandong Shanda Wit Science and Technology Co Ltd
sales of 1.80 billion Chinese Renmimbi [US$268.73 million]
of which 60%
Beximco Pharmaceuticals Limited
(22.82 billion Bangladeshi Taka [US$269.01 million]
Dong Wha Pharm Company Limited
based in KOREA (SOUTH)
(307.15 billion Korean Won [US$268.76 million]
of which 100%
Renata Limited reported sales of 22.81 billion Bangladeshi Taka (US$268.92 million)
June of 2019.
increase of 19.7%
versus 2018, when the company's sales were 19.05 billion Bangladeshi Taka.
Sales at Renata Limited have increased during each of the previous five years
(and since 2014, sales have increased a total of 100%).